About this trial
This study evaluates whether virtual reality (VR) audiovisual distraction can reduce pain, anxiety, and the need for pain and anxiety medications during prone pain procedures, compared to standard care alone. The trial design is a two-arm, parallel assignment, randomized controlled trial at a single site, the UC Davis Pain Medicine Clinic. Patients will be randomized in a 1:1 allocation to the intervention (commercially available virtual reality headset (Meta Quest 3) with audiovisual calming nature scene and an ergonomic cushion/support) vs control (standard medical care). The primary outcome will be a composite outcome analyzed using the Win Ratio method comparing opioid/sedative medication use, intra-procedural pain scores, and intra-procedural anxiety scores between groups. Approximately 230 people at UC Davis are expected to participate (Up to 20 patients for the preliminary run-in period to acclimatize research and clinical staff and 210 total for the randomized clinical trial). Each participant's involvement consists of one visit, estimated at 30 minutes.
Eligibility criteria
Qualifiers
Patients aged 18 years old or older
Male and female gender
Referred to UC Davis Pain Medicine Clinic and require a prone pain procedure
English speaking and with the ability to understand oral and written instructions
Disqualifiers
Pregnant women
Prisoners
Patients who have high risk of motion sickness
Seizure disorder
Trial design
Treatments tested in this trial
- Virtual Reality (VR) Audiovisual Distraction